Faiz Ullah Khan | Pharmacology | Outstanding Contribution Award

Published on by Environmental Scientists

Dr. Faiz Ullah Khan | Pharmacology | Outstanding Contribution Award

Dr. Faiz Ullah Khan | Pharmacology | Post-Doctoral Fellow at Peking University | Pakistan

Dr. Faiz Ullah Khan is a distinguished researcher and academic in the field of pharmacy and pharmaceutical sciences, currently affiliated with Peking University, where he has made significant contributions to clinical pharmacy, public health, and pharmacovigilance. Dr. Faiz Ullah Khan earned his PhD, MPhil, and PharmD degrees, equipping him with a robust educational foundation in clinical research, drug safety, and evidence-based pharmacy practice. Professionally, Dr. Faiz Ullah Khan has collaborated extensively with leading researchers and institutions globally, including Quaid-i-Azam University, Xi’an Jiaotong University, Prince of Songkla University, Jouf University, and the RCSI School of Pharmacy and Biomolecular Sciences, contributing to numerous international research projects in medication safety, antibiotic stewardship, and disease burden assessments.

Citation Metrics (Google Scholar)

2000

1600

1200

800

400

0

.

–

Citations
1659
i10index
45

h-index
23

🟦 Citations    🟥 i10index   🟩 h-index

View Google Scholar Profile

Featured Publications:

Clinical Case Studies on Medication Safety

– Elsevier, 2023 · 245 Citations
Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023

– Journal of the American College of Cardiology, 2025 · 64 Citations
Knowledge, Attitude, and Practices (KAPs) of Community Pharmacists Regarding COVID-19: A Cross-Sectional Survey in 2 Provinces of Pakistan

– Disaster Medicine and Public Health Preparedness, 2022 · 60 Citations
Global, Regional, and National Trends in Routine Childhood Vaccination Coverage from 1980 to 2023 with Forecasts to 2030: A Systematic Analysis for the Global Burden of Disease

– The Lancet, 2025 · 58 Citations
Knowledge, Attitude and Practices Among Consumers Toward Antibiotics Use and Antibiotic Resistance in Swat, Khyber-Pakhtunkhwa, Pakistan

– Expert Review of Anti-Infective Therapy, 2020 · 58 Citations

 

Alexandru Florea | Pharmaceutical Products | Research Excellence Award

Published on by Environmental Scientists

Dr. Alexandru Florea | Pharmaceutical products | Research Excellence Award

Biotehnos SA | Romania

Dr. Alexandru Florea is a dedicated chemist specializing in analytical chemistry, chromatographic techniques, bioanalytical studies, and mesoporous material synthesis, with a strong interdisciplinary background spanning pharmaceutical, environmental, and bioactive compound research. His expertise includes gas and liquid chromatography, tandem mass spectrometry, FT-IR, Raman spectroscopy, and advanced analytical protocols essential for investigating pesticides, heavy metals, and therapeutic compounds in diverse matrices. As an active contributor to research and development, he has participated in multiple national and European scientific projects focused on drug delivery systems, bioactive composites, phytochemical optimization, biopesticides, and innovative materials for medical and industrial applications. His work emphasizes analytical method development, experimental design, and the qualitative and quantitative characterization of natural compounds, pharmaceuticals, and complex mixtures. He has co-authored impactful publications on mesoporous silica composites, volatile oil encapsulation, metal transfer in medicinal plants, pesticide behavior, silica–plant extract composites, and nanoparticle applications in cancer research, demonstrating his ability to integrate chemical analysis with applied biological and pharmaceutical objectives. His research further extends to evaluating contaminants in herbal preparations, optimizing extraction processes, and advancing drug delivery through material engineering. He has gained substantial experience in laboratory management, chromatographic troubleshooting, spectrometric interpretation, and implementing standard operating procedures—reflecting strong organizational and technical skills. Through continued training and engagement in scientific seminars, he has strengthened his proficiency in analytical instrumentation and modern characterization techniques. With 54 citations by 54 documents, 7 published papers, and an h-index of 3, he stands out as a versatile chemist committed to innovation, scientific rigor, and advancing analytical and bioanalytical methodologies within pharmaceutical and environmental chemistry.

Profiles: Scopus | Orcid

Featured Publications

Florea, M.-A., Cristea, S., Perisoara, A., Tihauan, B.-M., Ene, M. D., Constantin, M., Ivan, E. Ș., Zala, R. C., Purcăreanu, B., Mihaiescu, D. E., et al. (2025). In vitro evaluation of the antifungal activity of Trigonella foenum-graecum seed extract and its potential application in plant protection. Plants, 14, 3320.

Purcăreanu, B., Ene, M. D., Moroșan, A., Mihaiescu, D. E., Florea, M.-A., Ghica, A., Niță, R. A., Drumea, V., Grigoroscuta, M. A., Kuncser, A., et al. (2023). Mesoporous composite bioactive compound delivery system for wound-healing processes. Pharmaceutics, 15, 2258.

Florea, M.-A., Drumea, V., Niță, R. A., Olariu, L., Georgiana Oana, T., & Gîrd, C. E. (2021). Transfer of some metals from medicinal plant used in phytotherapy, in different teas preparations. Toxicological and Environmental Chemistry, 103(6), 202–212.

Florea, M.-A. (2021). Optimization of the loading process of Artemisia absinthium volatile oil in a mesoporous material as drug delivery system. Biointerface Research in Applied Chemistry, 12(1), 450–464.

Florea, M.-A., Drumea, V., Niță, A.-R., Olariu, L., Costea, T., & Gîrd, C. E. (2020). Investigation of pesticide residues and heavy metals content in various peppermint samples. Farmacia, 68(4), 663–670.

Prof Dr. Claudio Bucolo | Pharmacology | Best Researcher Award

Published on by Environmental Scientists

Prof Dr. Claudio Bucolo | Pharmacology | Best Researcher Award

Prof Dr. Claudio Bucolo, University of Catania, Italy

Prof. Claudio Bucolo is a distinguished Full Professor of Pharmacology at the University of Catania. With a profound commitment to pharmacological research, particularly in the field of ophthalmology, Prof. Bucolo has garnered international recognition for his groundbreaking work. He has served as a Visiting Scholar at the Eye Research Institute, Oakland University, USA, and has received prestigious awards for his contributions to ocular pharmacology. He has authored over 225 scientific papers, filed 11 international patents, and continues to shape the scientific community with his leadership roles.

profile

Orcid

Strengths for the Award

Prof. Claudio Bucolo stands out as a strong candidate for the Best Researcher Award or Outstanding Scientist Award due to his remarkable achievements in the field of ocular pharmacology and neuropharmacology. He has received multiple prestigious international awards, such as the Dr. Roger Vogel Award and the Gold Fellow Medal for his contributions to ophthalmic disease treatments. With over 225 peer-reviewed publications, 11 international patents, and 8210 citations, his research has made a substantial impact. Additionally, his leadership roles in global conferences (ARVO) and editorial boards demonstrate his academic influence and dedication.

Areas for Improvement

While Prof. Bucolo’s expertise and leadership in ocular pharmacology are well-established, expanding his research focus to other domains of pharmacological research may increase his versatility and influence across broader scientific fields. Collaborating with more interdisciplinary teams could also enhance the global reach of his work. Furthermore, fostering young researchers through mentorship and expanding his role in educational initiatives can further strengthen his candidacy for future honors.

Education 🎓

Prof. Bucolo holds a comprehensive background in pharmacology, with advanced academic training and teaching roles at the University of Catania. His extensive experience as a Visiting Scholar at the Eye Research Institute, Oakland University (USA), has enriched his research perspectives and solidified his expertise in pharmacology applied to ophthalmology.

Experience 🧑‍🏫

Prof. Bucolo has had an illustrious career in academia and pharmacological research, holding key leadership positions at international conferences and organizations. He has served twice as President of the Pharmacology Section for the ARVO Conference Organizing Committee and as a board trustee for the Association for Ocular Pharmacology and Therapeutics. Additionally, he is Deputy Rector for Education in PhD Programs at the University of Catania and Director of the Research Center in Ocular Pharmacology (CERFO).

Research Interest 🔬

Prof. Bucolo’s primary research focuses on ocular pharmacology and neuropharmacology, investigating new drug therapies for ophthalmic diseases. His work contributes to understanding the pharmacodynamics and pharmacokinetics of novel treatments for vision-related disorders. He has made significant strides in neuroprotective strategies and drug delivery systems for ocular health.

Awards 🏆

Prof. Bucolo has received numerous accolades for his contributions to pharmacology and ophthalmology. Notable honors include the “Dr. Roger Vogel Award for Pharmaceutical Research” in 2015, the “Silver Fellow Medal” from the Association for Research in Vision and Ophthalmology (ARVO) in 2014, and the prestigious “Gold Fellow Medal” in 2019 for his outstanding service to the vision community. In 2019, he was also awarded the “Chancellor’s Award Guest” from Louisiana State University for his exceptional contributions to ophthalmic pharmacology.

Publication Top notes 📚

Bucolo C., et al. (2023). “Novel ocular drug delivery systems.” Journal of Ocular Pharmacology and Therapeutics. Cited by 50 articles. Link

Bucolo C., et al. (2022). “Neuroprotective agents in ophthalmology.” Experimental Eye Research. Cited by 40 articles. Link

Bucolo C., et al. (2020). “Advances in pharmacology for retinal diseases.” International Journal of Molecular Sciences. Cited by 65 articles. Link

Conclusion

Prof. Claudio Bucolo is a highly deserving candidate for both the Best Researcher Award and the Outstanding Scientist Award. His groundbreaking contributions to pharmacology, strong publication record, and international recognition solidify his reputation as a leading scientist in ophthalmic research. With a few strategic enhancements in interdisciplinary work and mentorship, his legacy in science could be even more profound.

Dr. Mona Kamal Saadeldin | Pharmacology | Best Researcher Award

Published on by Environmental Scientists

Dr. Mona Kamal Saadeldin | Pharmacology | Best Researcher Award

Dr. Mona Kamal Saadeldin, Researcher, University of Wisconsin Madison, United States

🌟 Dr. Mona Kamal Saadeldin is a distinguished researcher in pharmacology at the University of Wisconsin-Madison, United States. Her pioneering work in drug development and therapeutic interventions has earned her the prestigious Best Researcher Award 🏆. With a passion for advancing medical science, Dr. Saadeldin’s research focuses on novel treatments to improve patient outcomes 💊. She is celebrated for her innovative contributions and dedication to pharmacological research, making significant strides in the field. Her outstanding achievements and commitment to science continue to inspire and pave the way for future breakthroughs 🔬.

PROFILE 📝

Googlescholar

EDUCATION 🎓

🎓 Dr. Mona Kamal Saadeldin, a distinguished scholar in Pharmaceutical Sciences, earned her Ph.D. in Biochemistry and Molecular Biology from Al-Azhar University, Cairo, in 2017. She holds two M.Sc. degrees: one in Biotechnology from The American University in Cairo (2013) and another in Pharmaceutical Sciences from Al-Azhar University (2013) 🧬. Additionally, she completed a Diploma in Clinical Pharmacy at Ain-Shams University in 2009. Her academic journey began with a B.Sc. in Pharmaceutical Sciences from Ain-Shams University in 2006 🧪. Dr. Saadeldin’s diverse qualifications showcase her dedication to advancing pharmaceutical sciences 🌟.

RESEARCH EXPERIENCE 🔬

🌟 Dr. Mona Kamal Saadeldin is a dedicated researcher in Immuno-oncology at the University of Wisconsin-Madison, focusing on combining Targeted Radionuclide Therapy (TRT) and CAR-T cell therapy for solid tumors. She has led projects at the European Institute of Oncology and the University of Notre Dame, investigating cancer cell resistance and exosome characterization. 🧬💉 In Egypt, Dr. Saadeldin has contributed to diabetes and cancer research, including groundbreaking studies on Sclerostin, Irisin, and genetic variations in tumor suppressor genes. 📚🧪 As an educator, she has supervised and trained students, fostering future scientific innovation. 🌿👩‍🏫

CONFERENCE POSTER PRESENTATIONS 📊

Dr. Mona Kamal Saadeldin has made significant contributions to cancer and disease research, presenting her findings at various prestigious conferences. Her work on NFYC-AS1 lncRNA in cell cycle regulation was highlighted at the EMBO | EMBL Symposium (2021) 🧬. She explored osteocyte markers as diagnostic tools for atherosclerosis in type 2 diabetes at the ENABLE Conference in Copenhagen (2018) 🩺. Additionally, Dr. Saadeldin investigated soluble P-selectin levels as markers for diabetic nephropathy at the ESEO Conference (2018) 💉. Her research on genes in diagnosing urinary bladder and colon cancers was featured at the ENABLE Conference in Barcelona (2017) 🧫.

PROFESSIONAL MEMBERSHIPS 🤝

🎓 Dr. Mona Kamal Saadeldin has distinguished herself in the academic and research community with a diverse range of contributions. She served as a poster presentation judge at the Harper Cancer Research Institute’s 11th Annual Cancer Research event at the University of Notre Dame, IN, USA. 📚 Dr. Saadeldin is an Editorial Board Member for Frontiers in Molecular Biosciences, and an active member of the leadership team at NDnano Grad Student-Postdoc Group. 📝 She is the Main Guest Editor for a Methods Collection in JOVE and Co-guest Editor for a Special Issue in Cancers. Additionally, she reviews for multiple journals, including Frontiers in Pharmacology and Journal of Food Biochemistry. 🌟

AWARDS 🏆

🎓 Dr. Mona Kamal Saadeldin has a distinguished academic background, including postdoctoral fellowships at the University of Milan, Italy, focusing on noncoding-ome roles in cancer research (2021) and pharmacological target identification projects at the European Institute of Oncology (2021, 2018-2020). She received a PhD scholarship from the Ministry of Health, Cairo, Egypt, in 2015 and a Master’s scholarship in 2010. Additionally, Dr. Saadeldin earned a Master fellowship from the American University in Cairo in 2009. 🌟🔬 Her work contributes significantly to oncology and neurological research. 🧬💼

PUBLICATION TOP NOTES 📚

Anti-diabetic effects of fenugreek (Trigonella foenum-graecum): A comparison between oral and intraperitoneal administration – an animal study

Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis

Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study

Effects of Turmeric (Curcuma longa) Extract in streptozocin‐induced diabetic model

Tuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibition

Tuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibition

A critical review of chloroquine and hydroxychloroquine as potential adjuvant agents for treating people with cancer

Preclinical models of breast cancer: Two-way shuttles for immune checkpoint inhibitors from and to patient bedside

Thermal stability of a mercuric reductase from the Red Sea Atlantis II hot brine environment as analyzed by site-directed mutagenesis

Indolin-2-one derivatives as selective Aurora B kinase inhibitors targeting breast cancer